# Maryland Momentum Fund

> Maryland Momentum Fund is a VC fund in Baltimore backing Biotechnology and Software. See 13 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Baltimore, United States
- Total investments: 13
- Last investment: Feb 2022
- Lead investor: 31%
- Last updated: Aug 2026
- Website: http://momentum.usmd.edu/

Maryland Momentum Fund is an investment Fund

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 31% |
| Software | 2 | 15% |
| Health Care | 2 | 15% |
| Tea | 1 | 8% |
| SaaS | 1 | 8% |

40 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 38% |
| Funding Round | 3 | 23% |
| Pre-Seed | 2 | 15% |
| Grant | 1 | 8% |
| Series A | 1 | 8% |

6 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sunstone Credit | Sunstone Credit is on a mission to democratize access to solar for small and medium sized businesses (SMBs). Sitting at the intersection of climate, finance and technology, Sunstone has built a best-in-class technology platform and partnered with leading financial institutions and a national network of solar developers to provide SMB borrowersaccess to simple, affordable and easy-to-understand solar loan products with flexible terms and a streamlined application process. When SMB customers go solar using Sunstone’s products, they save money and reduce their carbon footprint, driving a clean, green future for all. Learn more at sunstonecredit.com. |  | Seed | Feb 10, 2022 |  |
| AquaLith Advanced Materials | AquaLith has exclusively licensed a portfolio of lithium-ion battery patents from the University of Maryland.Based on the work of Chunsheng Wang, the Robert Franklin and Frances Riggs Wright Distinguished Chair, Department of Chemical & Biomolecular Engineering, Department of Chemistry & Biochemistry, in collaboration with Kang Xu, ECSFellow, ARL Fellow, Team Leader, Senior Chemist at U.S. Army Research Laboratory. The technology includes a new ultra-high energy cathode, a novel silicon anode, and a non-flammable aqueous electrolyte. | $750K | Grant | Sep 08, 2021 |  |
| Liatris, Inc | Liatris is delivering the cleanest and fastest energy savings for businesses and consumers by mass producing high performance insulation. | $1M | Seed | Jul 30, 2021 |  |
| Veralox Therapeutics | Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients. | $16.6M | Series A | Jun 16, 2021 |  |
| miRecule | MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States. | $5.7M |  | May 28, 2021 |  |
| TargetDocs | Communication between general contractors and their vendors on construction projects is complex and fragmented, yet it’s mostly handled through email. Naturally, critical items get lost in personal inbox clutter. As a result, everyone suffers the financial impacts of project delays, disputes, and issues. TargetDocs bridges the gap between generalcontractors and vendors by connecting them through one communication workspace, so items never fall through the cracks and project teams are always on the same page.Learn more at www.targetdocs.com | $900K | Pre-Seed | Apr 19, 2021 |  |
| Dynamhex | Dynamhex monitors and visualizes complex energy consumption data for individual, corporate and government entities. By linking to science-based emission reduction targets, Dynamhex allows climate leaders to make data-driven decisions in a timely fight against climate change. | $1.5M | Seed | Mar 11, 2021 |  |
| Qualytics | Qualytics replaces reactive data firefighting with proactive, automated quality at scale. Our platform automates and maintains 95% of rules, aligning business and technical users in a single workflow. With governance, auditability, and security built-in, Qualytics delivers reliable data that drives faster decisions and AI readiness across theenterprise. | $3M | Pre-Seed | Jan 01, 2021 |  |
| NextStep Robotics | NextStep Robotics provides clinics the ability to offer personalized robotic therapy to patients through adaptive software that provides a personalized assist as needed approach. This is the first ever clinically proven option to effectively treat foot drop. Their robot is easy to use and designed to be run by lower skilled clinic staff freeing uptherapists to focus on more hands modalities. As they collect more data, the software will transition into an AI-based system to assess and assigns training protocols optimized for each patient’s deficit. The improved outcomes will allow clinics to provide reimbursable therapy using existing CPT codes for gait training on a patient base they currently have no treatment for. The device will be registered with the FDA as a Class 1 Exercise Device; and so, it can be sold and used WITHOUT FDA APPROVAL. Allowing NextStep Robotics to immediately generate revenue through: 1) Direct sales/leasing of robots; 2) Subscription to software service; 3) Service contracts. | $500K | Convertible Note | Aug 04, 2020 |  |
| Kalocyte | Kalocyte is a pre-clinical stage healthcare biotech startup company that provides artificial red blood cell substitutes used for trauma care related services. The company develops a demonstrated proof of concept for ErythroMer, a dried, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable,undesirable, or in short supply.Kalocyte was founded in 2016 and is headquartered in Baltimore, Maryland. | $300K | Seed | Jun 08, 2020 |  |

10 of 13 investments shown.

## Co-investors
- [University System of Maryland Momentum Fund](https://shizune.co/investors/profile/university-system-of-maryland) — VC Fund, 9 deals together
- [TEDCO](https://shizune.co/investors/profile/maryland-technology-development-corporation) — VC Fund, 3 deals together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 2 deals together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 2 deals together
- [The Chesapeake Bay Seed Capital Fund](https://shizune.co/investors/profile/the-chesapeake-bay-seed-capital-fund) — VC Fund, 2 deals together
- [Abell Foundation](https://shizune.co/investors/profile/abell-foundation) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Maryland Momentum Fund invest in?

Maryland Momentum Fund invests primarily in Biotechnology, Software and Health Care startups, most often at Seed and Funding Round stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Maryland Momentum Fund last invest?

The most recent investment recorded for Maryland Momentum Fund closed in Feb 2022. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co